Unknown

Dataset Information

0

Reversible Keap1 inhibitors are preferential pharmacological tools to modulate cellular mitophagy.


ABSTRACT: Mitophagy orchestrates the autophagic degradation of dysfunctional mitochondria preventing their pathological accumulation and contributing to cellular homeostasis. We previously identified a novel chemical tool (hereafter referred to as PMI), which drives mitochondria into autophagy without collapsing their membrane potential (??m). PMI is an inhibitor of the protein-protein interaction (PPI) between the transcription factor Nrf2 and its negative regulator, Keap1 and is able to up-regulate the expression of autophagy-associated proteins, including p62/SQSTM1. Here we show that PMI promotes mitochondrial respiration, leading to a superoxide-dependent activation of mitophagy. Structurally distinct Keap1-Nrf2 PPI inhibitors promote mitochondrial turnover, while covalent Keap1 modifiers, including sulforaphane (SFN) and dimethyl fumarate (DMF), are unable to induce a similar response. Additionally, we demonstrate that SFN reverses the effects of PMI in co-treated cells by reducing the accumulation of p62 in mitochondria and subsequently limiting their autophagic degradation. This study highlights the unique features of Keap1-Nrf2 PPI inhibitors as inducers of mitophagy and their potential as pharmacological agents for the treatment of pathological conditions characterized by impaired mitochondrial quality control.

SUBMITTER: Georgakopoulos ND 

PROVIDER: S-EPMC5583253 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Reversible Keap1 inhibitors are preferential pharmacological tools to modulate cellular mitophagy.

Georgakopoulos Nikolaos D ND   Frison Michele M   Alvarez Maria Soledad MS   Bertrand Hélène H   Wells Geoff G   Campanella Michelangelo M  

Scientific reports 20170904 1


Mitophagy orchestrates the autophagic degradation of dysfunctional mitochondria preventing their pathological accumulation and contributing to cellular homeostasis. We previously identified a novel chemical tool (hereafter referred to as PMI), which drives mitochondria into autophagy without collapsing their membrane potential (ΔΨ<sub>m</sub>). PMI is an inhibitor of the protein-protein interaction (PPI) between the transcription factor Nrf2 and its negative regulator, Keap1 and is able to up-re  ...[more]

Similar Datasets

| S-EPMC8607199 | biostudies-literature
| S-EPMC6449392 | biostudies-literature
| S-EPMC4245710 | biostudies-literature
| S-EPMC8266733 | biostudies-literature
| S-EPMC4716600 | biostudies-literature
| S-EPMC1184209 | biostudies-other
| S-EPMC6128040 | biostudies-literature
| S-EPMC6072017 | biostudies-literature
| S-EPMC7442609 | biostudies-literature
| S-EPMC5341618 | biostudies-literature